Hansoh Pharmaceutical Group Company Limited (FRA:3KY)

FRA:3KY Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	27,104	22,622	22,435	17,615	14,702	4,285
Short-Term Investments	-	780.44	1,937	1,471	1,882	9,241
Trading Asset Securities	17.55	17.24	512.41	2,544	2,357	200
Cash & Short-Term Investments	27,121	23,419	24,884	21,631	18,941	13,726
Cash Growth	15.42%	-5.88%	15.04%	14.20%	38.00%	-5.98%
Accounts Receivable	2,794	3,170	3,214	3,578	3,676	3,127
Other Receivables	-	94.27	80.89	47.42	52.74	82.82
Receivables	2,794	3,264	3,295	3,626	3,729	3,210
Inventory	653.49	651.22	575.78	447.89	410.13	298.73
Prepaid Expenses	-	0.88	3.83	1.73	0.97	2.11
Other Current Assets	250.62	106.41	124.83	125.6	98.05	48.61
Total Current Assets	30,819	27,442	28,883	25,832	23,179	17,286
Property, Plant & Equipment	3,203	3,247	3,280	3,450	3,475	2,304
Long-Term Investments	732.63	702.28	684.71	653.65	394.97	28.39
Other Intangible Assets	289.41	245.29	177.42	33.42	17.04	9.89
Other Long-Term Assets	27.26	21.32	13.93	33.29	93.4	1,164
Total Assets	35,071	31,658	33,039	30,002	27,160	20,792
Accounts Payable	268.65	217.85	163.76	222.3	248.33	124.38
Accrued Expenses	1,748	2,090	1,969	1,925	2,201	1,877
Current Portion of Long-Term Debt	40.98	40.87	4,183	-	-	-
Current Portion of Leases	17.13	16.01	16.09	15.54	9.97	11.04
Current Income Taxes Payable	138.77	46.67	85.65	90.94	134.2	11.4
Current Unearned Revenue	186.21	19.23	38.47	25.1	22.2	195.69
Other Current Liabilities	1,201	264.84	406.37	340.93	408.47	469.92
Total Current Liabilities	3,601	2,695	6,863	2,620	3,024	2,690
Long-Term Debt	-	-	39.74	4,283	3,743	-
Long-Term Leases	58.75	61.01	64.71	79.57	74.92	81.71
Long-Term Deferred Tax Liabilities	293.79	200.19	255.02	350.66	266.75	121.81
Other Long-Term Liabilities	21.28	21.52	21.99	22.46	22.93	23.4
Total Liabilities	3,975	2,978	7,244	7,355	7,131	2,916
Common Stock	0.05	0.05	0.05	0.05	0.05	0.05
Additional Paid-In Capital	-	14,000	14,096	13,932	14,024	14,009
Retained Earnings	-	13,918	11,405	8,780	6,910	4,578
Treasury Stock	-3.28	-13.22	-108.63	-28.03	-57.97	-
Comprehensive Income & Other	31,100	775.05	402.88	-36.91	-846.92	-710.99
Shareholders' Equity	31,097	28,680	25,795	22,647	20,029	17,876
Total Liabilities & Equity	35,071	31,658	33,039	30,002	27,160	20,792
Total Debt	116.86	117.89	4,304	4,378	3,828	92.75
Net Cash (Debt)	27,004	23,301	20,580	17,253	15,114	13,634
Net Cash Growth	15.51%	13.22%	19.29%	14.15%	10.86%	-6.55%
Net Cash Per Share	4.53	3.92	3.42	2.91	2.52	2.32
Filing Date Shares Outstanding	5,938	5,934	5,924	5,920	5,918	5,919
Total Common Shares Outstanding	5,938	5,934	5,924	5,920	5,918	5,919
Working Capital	27,218	24,747	22,020	23,212	20,156	14,596
Book Value Per Share	5.24	4.83	4.35	3.83	3.38	3.02
Tangible Book Value	30,807	28,435	25,617	22,614	20,012	17,866
Tangible Book Value Per Share	5.19	4.79	4.32	3.82	3.38	3.02
Buildings	-	2,481	2,324	2,311	2,279	1,325
Machinery	-	2,363	2,268	2,130	1,793	1,484
Construction In Progress	-	162.99	367.12	358.52	501.69	347.73
Leasehold Improvements	-	48.1	48.1	41.25	10.9	9.93

Source: S&P Global Market Intelligence. Standard template. Financial Sources.